Chinook Therapeutics, Inc. Debt to Equity Ratio 2015-2023 | KDNY
Current and historical debt to equity ratio values for Chinook Therapeutics, Inc. (KDNY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Chinook Therapeutics, Inc. debt/equity for the three months ending June 30, 2023 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-06-30 |
$0.13B |
$0.36B |
0.37 |
2023-03-31 |
$0.13B |
$0.41B |
0.32 |
2022-12-31 |
$0.13B |
$0.44B |
0.30 |
2022-09-30 |
$0.12B |
$0.48B |
0.24 |
2022-06-30 |
$0.09B |
$0.51B |
0.19 |
2022-03-31 |
$0.10B |
$0.43B |
0.25 |
2021-12-31 |
$0.11B |
$0.45B |
0.24 |
2021-09-30 |
$0.11B |
$0.27B |
0.42 |
2021-06-30 |
$0.11B |
$0.30B |
0.38 |
2021-03-31 |
$0.10B |
$0.30B |
0.33 |
2020-12-31 |
$0.09B |
$0.34B |
0.28 |
2020-09-30 |
$0.21B |
$0.04B |
6.15 |
2020-06-30 |
$0.22B |
$0.05B |
4.69 |
2020-03-31 |
$0.23B |
$0.06B |
3.79 |
2019-12-31 |
$0.06B |
$-0.04B |
-1.38 |
2019-09-30 |
$0.23B |
$0.08B |
2.82 |
2019-06-30 |
$0.24B |
$0.10B |
2.35 |
2019-03-31 |
$0.24B |
$0.12B |
2.08 |
2018-12-31 |
$0.22B |
$0.14B |
1.64 |
2018-09-30 |
$0.21B |
$0.16B |
1.34 |
2018-06-30 |
$0.22B |
$0.18B |
1.26 |
2018-03-31 |
$0.23B |
$0.20B |
1.15 |
2017-12-31 |
$0.21B |
$0.24B |
0.87 |
2017-09-30 |
$0.21B |
$0.26B |
0.81 |
2017-06-30 |
$0.21B |
$0.26B |
0.80 |
2017-03-31 |
$0.21B |
$0.23B |
0.90 |
2016-12-31 |
$0.21B |
$0.23B |
0.93 |
2016-09-30 |
$0.22B |
$0.25B |
0.87 |
2016-06-30 |
$0.22B |
$0.25B |
0.91 |
2016-03-31 |
$0.23B |
$0.24B |
0.95 |
2015-12-31 |
$0.22B |
$0.26B |
0.84 |
2015-09-30 |
$0.22B |
$0.24B |
0.88 |
2015-06-30 |
$0.23B |
$0.24B |
0.96 |
2015-03-31 |
$0.05B |
$0.09B |
0.58 |
2014-12-31 |
$0.05B |
$0.08B |
0.61 |
2014-09-30 |
$0.00B |
|
0.00 |
2014-06-30 |
$0.00B |
|
0.00 |
2014-03-31 |
$0.00B |
|
0.00 |